(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid Struktur
1229337-32-9
CAS-Nr.
1229337-32-9
Englisch Name:
(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
Synonyma:
Narlaprevir intermediate;(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid;3-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)-
CBNumber:
CB62623452
Summenformel:
C26H45N3O6S
Molgewicht:
527.72
MOL-Datei:
1229337-32-9.mol

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid Eigenschaften

Siedepunkt:
751.2±45.0 °C(Predicted)
Dichte
1.22±0.1 g/cm3(Predicted)
pka
3.50±0.40(Predicted)

Sicherheit

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
Haoyuan Chemexpress Co., Ltd. 021-58950125
info@chemexpress.com China 7553 61
Lanzhou Angeli Biochemical Technology Co., Ltd. 0931-8235634 13321316780
1455540579@qq.com China 959 55
Shanghai Kaiwei Chemical Technology Co., Ltd. 021-58461859 15821823057
service@aiviche.com China 49323 58
Shanghai Haohong Pharmaceutical Co., Ltd. 400-400-8210725 4008210725
malulu@leyan.com China 55023 58
MeiKe medicine technology (Foshan City) Co., LTD 18029359586
sales@mkmeditech.com China 789 58
https://hanhongsci.com/ 021-54306202 18917919676
info@hanhongsci.com China 29989 58
Nantong Hanfang Biotechnology Co. , Ltd. 3674309880
hanfangpharma@126.com China 30968 58

  • (1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylMethyl)cyclohexyl)ureido)-3,3-diMethylbutanoyl)-6,6-diMethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
  • Narlaprevir intermediate
  • 3-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)-
  • 1229337-32-9
Copyright 2019 © ChemicalBook. All rights reserved